The proposed mechanism of action in ADPKD is by stimulating AMPK activation, which negatively regulates both the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) from the apical membrane and mTOR pathway. Here, MTOR is linked to autosomal dominant polycystic kidney disease.